Analysts Are Downgrading These 10 Pharmaceutical Stocks

In this article, we present the 10 pharmaceutical stocks that are being downgraded by analysts.

Related Keywords

California ,United States ,Utah ,American ,Michael Ryskin ,Gregory Fraser ,Kalpit Patel ,Mara Goldstein ,Raymond James ,Gena Wang ,Chris Shibutani ,Elliot Wilbur ,Recursion Pharmaceuticals Inc ,Deloitte ,Goldman Sachs ,Number Of Hedge Fund Holders ,Nasdaq ,American Association For Cancer Research ,Pfizer Inc ,Biocryst Pharmaceuticals Inc ,Abbvie Inc ,Antares Pharma Inc ,Bristol Myers Squibb Co ,Barclays ,Analysts Are Downgrading These ,Hedge Fund Holders ,Recursion Operating System ,Recursion Pharmaceuticals ,American Association ,Cancer Research ,Nektar Therapeutics ,Insider Monkey ,Cryst Pharmaceuticals ,North Carolina Based ,Equal Weight ,Antares Pharma ,Market Perform ,Strong Buy ,Bicycle Therapeutics ,